cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neuronetics Inc
4 own
8 watching
Current Price
$2.34
$0.63
(36.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
23.63M
52-Week High
52-Week High
5.070000
52-Week Low
52-Week Low
0.51999998
Average Volume
Average Volume
10.26M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization23.63M
icon52-Week High5.070000
icon52-Week Low0.51999998
iconAverage Volume10.26M
iconDividend Yield--
iconP/E Ratio--
What does the Neuronetics Inc do?
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.
Read More
How much money does Neuronetics Inc make?
News & Events about Neuronetics Inc.
Globe Newswire
1 year ago
The Company expands technology for patients with obsessive-compulsive disorderMALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who ...
Globe Newswire
1 year ago
MALVERN, Pa., May 05, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of...
Globe Newswire
1 year ago
Data highlights the Companys commitment to advancing TMS and improving patient outcomesMALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of ...
Globe Newswire
1 year ago
Campaign features patients experiences to support others with depressionA Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company ...
Globe Newswire
1 year ago
Strategic role strengthens NeuroStar Advanced Therapy commercialization teamMALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...
Frequently Asked Questions
Frequently Asked Questions
What is Neuronetics Inc share price today?
plus_minus_icon
Can Indians buy Neuronetics Inc shares?
plus_minus_icon
How can I buy Neuronetics Inc shares from India?
plus_minus_icon
Can Fractional shares of Neuronetics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neuronetics Inc stocks?
plus_minus_icon
What is today’s traded volume of Neuronetics Inc?
plus_minus_icon
What is today’s market capitalisation of Neuronetics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neuronetics Inc?
plus_minus_icon
What percentage is Neuronetics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neuronetics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.34
$0.63
(36.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00